CEO, CFO, others buying at Titan Medical (T:TMD)

Martin Bernholtz, a Senior Officer, acquired 1,000,000 Common Shares at a price of $0.150 and 1,000,000 Warrants exercisable at $0.200 for a period of five years on an indirect ownership basis for registered holder Accretive Capital Corp through a prospectus or prospectus exempt offering on July 4th, 2017. This represents a $150,000 investment into the company's shares and an account share holdings change of greater than 100%.

On the same terms:
 
John Barker, a Director, acquired 150,000 Common Shares and 150,000 Warrants on a direct ownership basis through a prospectus or prospectus exempt offering on June 29th, 2017. Mr. Barker also acquired 50,000 Common Shares and 50,000 Warrants on an indirect ownership basis for registered holder Sandra Barker as through a prospectus or prospectus exempt offering on June 29th, 2017. This represents a $30,000 investment into the company's shares and an account share holdings change of greater than 100%.

Stephen Randall, CFO, acquired 160,000 Common Shares and 160,000 Warrants on a direct ownership basis  through a prospectus or prospectus exempt offering on June 29th, 2017. This represents a $24,000 investment into the company's shares and an account share holdings change of 91.6%.

David John McNally, CEO, acquired 30,000 Common Shares and 30,000 Warrants on a direct ownership basis at a price of $0.150 through a prospectus or prospectus exempt offering on June 29th, 2017. This represents a $4,500 investment into the company's shares and an account share holdings change of greater than 100%.

Bruce Gilles Wolff, a Director, acquired 17,747 Common Shares and 17,747 Warrants on a direct ownership basis at a price of $0.150 through a prospectus or prospectus exempt offering on June 29th, 2017. This represents a $2,662 investment into the company's shares and an account share holdings change of greater than 100%.

Titan Medical is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.

Titan Medical Inc. is a Canada-based company engaged in developing robotic surgical system for use in connection with minimally invasive surgery (MIS) (surgery without large incisions). The Company is developing the SPORT (Single Port Orifice Robotic Technology) Surgical System, a single-port/single-incision robotic surgical system to provide tele-operation (remote surgery) capabilities. The SPORT Surgical System comprises a surgeon-controlled robotic platform (patient cart) that includes a three dimensional (3D) high definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides the surgeon with an ergonomic interface to the robotic platform and also provides a 3D endoscopic view of inside a patient's body during MIS procedures. The SPORT Surgical System is also being developed to allow for data collection and analytics that could be utilized by the surgeon and/or operation room teams. Titan Medical Inc. (TMD) has below median officer and director direct ownership compared to its micro-cap peers in the market, based on our estimate using SEDI data. According to regulatory filings yesterday, five insiders have invested a total amount of $211,162.